Through its focus on the fuel supply that powers healthy brain function, a transformative study has uncovered both the key cause and an immediate treatment for Parkinson’s disease.
Researchers reported their discovery last week that brain cells in Parkinson’s patients shut down the energy-producing capacity of the mitochondria, resulting in a devastating shortage for cells that normally consume 20 percent of the body’s energy.
The findings indicate that boosting the mitochondria with current FDA approved drugs early on may prevent or delay the onset of Parkinson’s.
